Document ID: FDA-2015-N-0001-0110
Agency: fda
Document Type: Notice
Title: The Twentieth Food and Drug Administration International Separation Science Society Symposium on the Interface of Regulatory and Analytical Sciences for Biotechnology Health Products—WCBP 2016
Posted Date: 2015-12-17T05:00Z

[Federal Register Volume 80, Number 242 (Thursday, December 17, 2015)]
[Notices]
[Pages 78742-78743]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-31691]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No.FDA-2015-N-0001]

The Twentieth Food and Drug Administration International 
Separation Science Society Symposium on the Interface of Regulatory and 
Analytical Sciences for Biotechnology Health Products--WCBP 2016

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration's (FDA) Center for Drug 
Evaluation and Research, in cosponsorship with the International 
Separation Science Society (CASSS), is announcing a meeting entitled 
``The Twentieth FDA CASSS Symposium on the Interface of Regulatory and 
Analytical Sciences for Biotechnology Health Products--WCBP 2016.'' The 
purpose of the meeting is to discuss development of biotechnology-
derived drug products and analytic methodologies for the development of 
biotechnology-derived drug products.

DATES: The meeting will be held January 26, 2016, from 8 a.m., until 
January 28, 2016, at 5 p.m.

ADDRESSES: The meeting will be held at The Mayflower Hotel, 1127 
Connecticut Ave. NW., Washington, DC

FOR FURTHER INFORMATION CONTACT: Linda Mansouria, CASSS, 5900 Hollis 
St., Suite R3, Emeryville, CA 94608, 510-428-0740, FAX: 510-428-0741, 
lmansouria@casss.org.

SUPPLEMENTARY INFORMATION: 

I. Background

    CASSS is a scientific society providing forums for the 
dissemination of information and discussions among industry, academic 
and regulatory professionals founded on the development and 
applications of separation science. This cosponsored meeting provides 
state-of-the-art presentations on the technologies used to produce and 
assess product quality of biotechnology-derived drug products.

II. Registration and Accommodations

A. Registration

    There is a registration fee to attend this meeting. The 
registration fee is charged to help defray the costs of programming and 
facilities. Seats are limited, and registration will be on a first-
come, first-served basis.
    To register, please complete registration online at http://www.casss.org/?WCBP1600. (FDA has verified the Web address, but FDA is 
not responsible for subsequent changes to the Web site after this 
document publishes in the Federal Register.) The costs of registration 
for the different categories of attendees are as follows:

------------------------------------------------------------------------
                 Category                               Cost
------------------------------------------------------------------------
Industry Representatives..................  $1995 (early bird);
                                            $2395 (onsite).
Academic..................................  $795 (early bird);
                                            $895 (onsite).
Government................................  $795 (early bird);
                                            $895 (onsite).
------------------------------------------------------------------------

B. Accommodations

    Attendees are responsible for their own hotel accommodations. 
Attendees making reservations at the Mayflower Hotel in Washington DC 
are eligible for a reduced rate of $295 USD, not including applicable 
taxes. To receive the reduced rate, contact the Mayflower

[[Page 78743]]

Hotel (1-877-212-5752) and identify yourself as an attendee of 
``CASSS--WCBP 2016.'' If you need special accommodations due to a 
disability, please contact Linda Mansouria (see FOR FURTHER INFORMATION 
CONTACT) at least 7 days in advance.

III. Transcripts

    We expect that transcripts will be available approximately 30 days 
after the meeting. A transcript will be available in either hard copy 
or on CD-ROM, after submission of a Freedom of Information request. 
Send written requests to the Division of Freedom of Information (ELEM-
1029), Food and Drug Administration, 12420 Parklawn Dr., Element Bldg., 
Rockville, MD 20857. Send faxed requests to 301-827-9267.

    Dated: December 11, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015-31691 Filed 12-16-15; 8:45 am]
BILLING CODE 4164-01-P